Health Canada to review U.S. panel's conclusion that common decongestant doesn't work
CTV
Health Canada says it will review a declaration by American government experts who say a key ingredient in over-the-counter cold and allergy medications also available in this country does not work to get rid of nasal and sinus congestion.
Health Canada says it will review a declaration by American government experts who say a key ingredient in over-the-counter cold and allergy medications also available in this country does not work to get rid of nasal and sinus congestion.
Advisers to the U.S. Food and Drug Administration voted unanimously this week against the effectiveness oforally administered decongestantphenylephrine, found in medicationssuch as Sudafed and DayQuil.
The FDA must still decide whether to revoke the over-the-counter designation for medications containing phenylephrine, meaning they may need to be removed from store shelves.
Phenylephrine became a common ingredient in cold and allergy medicines after a 2006 U.S. law banned over-the-counter sales of products that contain another type of decongestant called pseudoephedrine, which, in large quantities, can be used to make methamphetamine.
That version is kept behind pharmacy counters.
Health Canada said Friday that, following a review, it will take any necessary action to ensure Canadians have access to safe and effective products.
Various studies have already questioned the benefits of phenylephrine, which is also available in nasal sprays, though the FDA said its advisory committee's latest vote only relates to phenylephrine in oral form, not the nasal spray.
Tropical storm Sara drenches Honduras’ northern coast, with flash flooding and mudslides in forecast
Tropical storm Sara stalled over Honduras on Saturday. The area could see life-threatening flash flooding and mudslides through the weekend.